Parallax Volatility Advisers »

Bridgebio Pharma shares owned by Parallax Volatility Advisers

Quarter-by-quarter ownership of Bridgebio Pharma (BBIO) shares owned by Parallax Volatility Advisers from 13F filings

Historical chart of Parallax Volatility Advisers investment in Bridgebio Pharma

Tip: Access up to 7 years of quarterly data

All positions including Bridgebio Pharma held by Parallax Volatility Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bridgebio Pharma by Parallax Volatility Advisers

Quarter filed Position value Share count Share price at filing
2023-12-31 $13M 309k 40.37
2023-09-30 $1.2M 44k 26.37
2023-06-30 $402k 23k 17.20
2023-03-31 $1.7M 100k 16.58
2021-09-30 $17M 353k 46.87
2021-06-30 $25M 412k 60.96
2021-03-31 $26M 420k 61.60

More positions owned by Parallax Volatility Advisers

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Meta Platforms Cl A Call Option (META)
NVIDIA Corporation (NVDA)
Tesla Motors Call Option (TSLA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Spdr Gold Tr Gold Shs Put Option (GLD)
Select Sector Spdr Tr Energy (XLE)
Pdd Holdings Sponsored Ads Put Option (PDD)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
Palo Alto Networks (PANW)
Amazon (AMZN)
Royal Caribbean Cruises Put Option (RCL)

View all positions for Parallax Volatility Advisers

Top funds holding Bridgebio Pharma

Kohlberg Kravis Roberts & Co
Viking Global Investors
Vanguard Group
Aisling Capital Management
Laurion Capital Management
Cormorant Asset Management
Goldman Sachs Group
Lord, Abbett & Co
Frazier Life Sciences Management
Alliancebernstein
Perceptive Advisors
Citigroup
Wellington Management Company
Hillhouse Capital Advisors
Norges Bank Investment Management

View all funds holding Bridgebio Pharma